225 related articles for article (PubMed ID: 30312362)
1. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
[TBL] [Abstract][Full Text] [Related]
2. Association between duration of antipseudomonal beta-lactam therapy and
Hawkins AM; Raux B; Weeda E; Hornback KM
Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e25. PubMed ID: 36310778
[TBL] [Abstract][Full Text] [Related]
3. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
Augustine MR; Testerman TL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Infect Control Hosp Epidemiol; 2017 Mar; 38(3):266-272. PubMed ID: 27989244
[TBL] [Abstract][Full Text] [Related]
4. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
López-Cortés LE; Rosso-Fernández C; Núñez-Núñez M; Lavín-Alconero L; Bravo-Ferrer J; Barriga Á; Delgado M; Lupión C; Retamar P; Rodríguez-Baño J;
BMJ Open; 2017 Jun; 7(6):e015439. PubMed ID: 28601833
[TBL] [Abstract][Full Text] [Related]
5. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.
Nelson AN; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Infection; 2017 Oct; 45(5):613-620. PubMed ID: 28478600
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Falcone M; Russo A; Iraci F; Carfagna P; Goldoni P; Vullo V; Venditti M
Antimicrob Agents Chemother; 2016 Jan; 60(1):252-7. PubMed ID: 26482315
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.
Al-Jaghbeer MJ; Justo JA; Owens W; Kohn J; Bookstaver PB; Hucks J; Al-Hasan MN
Infection; 2018 Aug; 46(4):487-494. PubMed ID: 29752649
[TBL] [Abstract][Full Text] [Related]
8. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors.
Al-Hasan MN; Gould AP; Drennan C; Hill O; Justo JA; Kohn J; Bookstaver PB
J Glob Antimicrob Resist; 2020 Sep; 22():87-93. PubMed ID: 31887412
[TBL] [Abstract][Full Text] [Related]
9. Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort.
Palacios-Baena ZR; Delgado-Valverde M; Valiente Méndez A; Almirante B; Gómez-Zorrilla S; Borrell N; Corzo JE; Gurguí M; De la Calle C; García-Álvarez L; Ramos L; Gozalo M; Morosini MI; Molina J; Causse M; Pascual Á; Rodríguez-Baño J;
Clin Infect Dis; 2019 Aug; 69(6):956-962. PubMed ID: 30535051
[TBL] [Abstract][Full Text] [Related]
10. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
Bartoletti M; Tedeschi S; Pascale R; Raumer L; Maraolo AE; Palmiero G; Tumietto F; Cristini F; Ambretti S; Giannella M; Lewis RE; Viale P
Int J Antimicrob Agents; 2018 Mar; 51(3):516-521. PubMed ID: 29410250
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Giannella M; Pascale R; Ferraro G; Toschi A; Pancaldi L; Furii F; Bartoletti M; Tedeschi S; Ambretti S; Lewis RE; Viale P
Int J Antimicrob Agents; 2019 May; 53(5):574-581. PubMed ID: 30639527
[TBL] [Abstract][Full Text] [Related]
12. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.
Battle SE; Bookstaver PB; Justo JA; Kohn J; Albrecht H; Al-Hasan MN
J Antimicrob Chemother; 2017 Jan; 72(1):299-304. PubMed ID: 27986899
[TBL] [Abstract][Full Text] [Related]
13. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents.
Mediwala KN; Kohn JE; Bookstaver PB; Justo JA; Rac H; Tucker K; Lashkova L; Dash S; Al-Hasan MN
Am J Infect Control; 2019 Nov; 47(11):1284-1289. PubMed ID: 31221448
[TBL] [Abstract][Full Text] [Related]
14. Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?
Ulrich RJ; Santhosh K; Mogle JA; Young VB; Rao K
Anaerobe; 2017 Dec; 48():27-33. PubMed ID: 28669864
[TBL] [Abstract][Full Text] [Related]
15. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.
Al-Hasan MN; Acker EC; Kohn JE; Bookstaver PB; Justo JA
Pharmacotherapy; 2018 Jan; 38(1):42-50. PubMed ID: 29105102
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.
Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Int J Antimicrob Agents; 2018 Mar; 51(3):488-492. PubMed ID: 28919195
[TBL] [Abstract][Full Text] [Related]
17. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
Bookstaver PB; Nimmich EB; Smith TJ; Justo JA; Kohn J; Hammer KL; Troficanto C; Albrecht HA; Al-Hasan MN
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630187
[TBL] [Abstract][Full Text] [Related]
18. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae.
Hammer KL; Stoessel A; Justo JA; Bookstaver PB; Kohn J; Derrick CB; Albrecht H; Al-Hasan MN
Am J Infect Control; 2016 Dec; 44(12):1611-1616. PubMed ID: 27499192
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams.
Mercuro NJ; Stogsdill P; Wungwattana M
Int J Antimicrob Agents; 2018 May; 51(5):687-692. PubMed ID: 29284155
[TBL] [Abstract][Full Text] [Related]
20. De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.
Shime N; Satake S; Fujita N
Infection; 2011 Aug; 39(4):319-25. PubMed ID: 21509424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
